In humans, the MKLN1 gene is located on the long arm of chromosome 7 (7q32.3).[7] It produces 12 splice variant transcripts, 6 of which are translated into a protein product.[8] It is widely expressed across human tissues.[9]
At its N-terminus, muskelin has a disicoidin domain. This is followed by the alpha helical domains Lis1 Homology (LisH) and C-terminal to LisH (CTLH). After these lies the kelch repeatβ-propellor domain, followed at the C-terminus by the CRA domain. Muskelin acts as a scaffold in the C-terminal to LisH (CTLH) E3 ligase complex. It is one of two proteins, along with WDR26, that can facilitate the formation of a massive supramolecular structure (600 kDa).[10]
Muskelin is a component of the CTLH complex, which assembles into distinct supramolecular structures depending on whether WDR26 or muskelin acts as the β-propeller subunit. The CTLH complex is a recently characterized RING E3 ubiquitin ligase. As an E3 ligase, it catalyzes the final step of the ubiquitination cascade by mediating the interaction between a ubiquitin-conjugating enzyme (E2) and the substrate protein targeted for ubiquitination.[11] The CTLH complex primarily functions within the ubiquitin-proteasome system, tagging proteins for degradation by the 26S proteasome.
The complex consists of several core components. Its structural scaffold is formed by RanBPM, GID8, and ARMC8. The RING heterodimer, composed of RMND5A and MAEA, is responsible for the complex’s E3 ligase activity by directly interacting with the E2 enzyme. GID4 functions as the primary substrate receptor, recognizing and recruiting proteins targeted for ubiquitination.[10]
WDR26 and muskelin act in a mutually exclusive manner to promote the assembly of a higher-order CTLH structure, which includes four scaffold units, two RING heterodimers, and two GID4 receptors. WDR26 achieves this through binding as a pair of homodimers, while muskelin binds as a pair of homotetramers, each inserting between scaffold units to stabilize the supramolecular structure.[10]
These WDR26- and muskelin-containing complexes are functionally distinct due to differences in their substrate-binding interfaces. This structural variation enables them to recruit different sets of substrates. In muskelin knockout cells, expression levels of 39 proteins are altered, 16 of which are also affected by WDR26 knockout, indicating 23 proteins are specifically regulated by the muskelin-containing CTLH complex.[12]
The muskelin-containing complex also regulates its own activity via a negative feedback mechanism. It has been shown to ubiquitinate and promote the degradation of muskelin itself, a process not observed with WDR26 or other subunits.[13][12] This autoregulation substitutes for alternative substrate receptors, helping maintain appropriate substrate levels.[12]
The CTLH complex was first discovered in Saccharomyces cerevisiae (Brewer's yeast), however here it lacks a muskelin homologue. Similarly, it also lacks a muskelin homologue in plants and nematodes, however it does exist in higher order animals such as mammals, fish and amphibians.[10]
The CTLH complex is mostly implicated in neurological conditions. The most well understood of these is Skraban–Deardorff syndrome, a neurodevelopmental disorder caused by a multitude of WDR26 mutations impairing its ability to form the supramolecular structure.[16] A particular muskelin SNP has been linked withn early-onset bipolar disorder via a genome-wide association study, however the biological mechanism for this is unclear.[17]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Adams JC, Zhang L (May 2000). "cDNA cloning of human muskelin and localisation of the muskelin (MKLN1) gene to human chromosome 7q32 and mouse chromosome 6 B1/B2 by physical mapping and FISH". Cytogenetics and Cell Genetics. 87 (1–2): 19–21. doi:10.1159/000015385. PMID10640805. S2CID7919425.
^Prag S, De Arcangelis A, Georges-Labouesse E, Adams JC (2007-01-01). "Regulation of post-translational modifications of muskelin by protein kinase C". The International Journal of Biochemistry & Cell Biology. 39 (2): 366–378. doi:10.1016/j.biocel.2006.09.003. PMID17049906.
^Nassan M, Li Q, Croarkin PE, Chen W, Colby CL, Veldic M, et al. (January 2017). "A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis model". Journal of Affective Disorders. 208: 120–129. doi:10.1016/j.jad.2016.09.049. PMID27769005.
Hasegawa H, Katoh H, Fujita H, Mori K, Negishi M (September 2000). "Receptor isoform-specific interaction of prostaglandin EP3 receptor with muskelin". Biochemical and Biophysical Research Communications. 276 (1): 350–354. doi:10.1006/bbrc.2000.3467. PMID11006128.
Umeda M, Nishitani H, Nishimoto T (January 2003). "A novel nuclear protein, Twa1, and Muskelin comprise a complex with RanBPM". Gene. 303: 47–54. doi:10.1016/S0378-1119(02)01153-8. PMID12559565.
Kobayashi N, Yang J, Ueda A, Suzuki T, Tomaru K, Takeno M, et al. (July 2007). "RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex". Gene. 396 (2): 236–247. doi:10.1016/j.gene.2007.02.032. PMID17467196.